TET2 mutation is an independent favorable prognostic factor in myelodysplastic syndromes (MDSs). (Q27851480)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | TET2 mutation is an independent favorable prognostic factor in myelodysplastic syndromes (MDSs). |
scientific article |
Statements
TET2 mutation is an independent favorable prognostic factor in myelodysplastic syndromes (MDSs) (English)
Pierre Fenaux
Odile Beyne-Rauzy
Norbert Vey
Véronique Gelsi-Boyer
Groupe Francophone des Myélodysplasies
Véronique Della-Valle
Eric Delabesse
Sophie Grabar
Françoise Picard
Franck Viguié
Véronique Mansat-De Mas
Philippe Guardiola
François Dreyfus
Mathilde Hunault-Berger
7 August 2009
Identifiers
2 references
2 references